RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kobayashi Pharmaceutical Co Stock

Kobayashi Pharmaceutical Co Revenue 2024

Kobayashi Pharmaceutical Co Revenue

174.69 B JPY

Ticker

4967.T

ISIN

JP3301100008

WKN

920477

In 2024, Kobayashi Pharmaceutical Co's sales reached 174.69 B JPY, a 0.71% difference from the 173.46 B JPY sales recorded in the previous year.

The Kobayashi Pharmaceutical Co Revenue history

YEARREVENUE (undefined JPY)GROSS MARGIN (%)
2026e192.5450,06
2025e184.5252,23
2024e174.6955,17
2023173.4655,56
2022166.2655,53
2021155.2557,18
2020150.5156,65
2019158.3457,46
2018167.4861,57
2017156.7660,94
2016120.0559,49
2015137.2158,08
2014128.3457,37
2013127.2957,43
2012121.5357,43
2011131.1758,35
2010130.8257,28
2009129.1855,73
2008125.6954,76
2007228.8333,60
2006257.0231,56
2005246.8531,13
2004215.7132,07

Kobayashi Pharmaceutical Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Kobayashi Pharmaceutical Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Kobayashi Pharmaceutical Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Kobayashi Pharmaceutical Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Kobayashi Pharmaceutical Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Kobayashi Pharmaceutical Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Kobayashi Pharmaceutical Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Kobayashi Pharmaceutical Co’s growth potential.

Kobayashi Pharmaceutical Co Revenue, EBIT and net profit per share

DateKobayashi Pharmaceutical Co RevenueKobayashi Pharmaceutical Co EBITKobayashi Pharmaceutical Co Net Income
2026e192.54 B undefined0 undefined20.53 B undefined
2025e184.52 B undefined0 undefined19.54 B undefined
2024e174.69 B undefined0 undefined16.27 B undefined
2023173.46 B undefined25.78 B undefined20.34 B undefined
2022166.26 B undefined26.67 B undefined20.02 B undefined
2021155.25 B undefined26.07 B undefined19.72 B undefined
2020150.51 B undefined25.94 B undefined19.21 B undefined
2019158.34 B undefined25.66 B undefined19.14 B undefined
2018167.48 B undefined26.29 B undefined18.02 B undefined
2017156.76 B undefined22.93 B undefined15.86 B undefined
2016120.05 B undefined17.41 B undefined14.32 B undefined
2015137.21 B undefined18.26 B undefined13.47 B undefined
2014128.34 B undefined17.92 B undefined12.45 B undefined
2013127.29 B undefined18.12 B undefined12.31 B undefined
2012121.53 B undefined16.9 B undefined12.18 B undefined
2011131.17 B undefined19.3 B undefined11.73 B undefined
2010130.82 B undefined18.63 B undefined9.34 B undefined
2009129.18 B undefined17.05 B undefined9.25 B undefined
2008125.69 B undefined15.83 B undefined8.85 B undefined
2007228.83 B undefined14.29 B undefined8.51 B undefined
2006257.02 B undefined14.44 B undefined8.3 B undefined
2005246.85 B undefined14.13 B undefined7.44 B undefined
2004215.71 B undefined13 B undefined6.69 B undefined

Kobayashi Pharmaceutical Co stock margins

The Kobayashi Pharmaceutical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Kobayashi Pharmaceutical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Kobayashi Pharmaceutical Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Kobayashi Pharmaceutical Co's sales revenue. A higher gross margin percentage indicates that the Kobayashi Pharmaceutical Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Kobayashi Pharmaceutical Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Kobayashi Pharmaceutical Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Kobayashi Pharmaceutical Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Kobayashi Pharmaceutical Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Kobayashi Pharmaceutical Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Kobayashi Pharmaceutical Co Margin History

Kobayashi Pharmaceutical Co Gross marginKobayashi Pharmaceutical Co Profit marginKobayashi Pharmaceutical Co EBIT marginKobayashi Pharmaceutical Co Profit margin
2026e55.56 %0 %10.67 %
2025e55.56 %0 %10.59 %
2024e55.56 %0 %9.31 %
202355.56 %14.86 %11.73 %
202255.53 %16.04 %12.04 %
202157.18 %16.79 %12.7 %
202056.65 %17.24 %12.76 %
201957.46 %16.2 %12.09 %
201861.57 %15.7 %10.76 %
201760.94 %14.62 %10.12 %
201659.49 %14.5 %11.93 %
201558.08 %13.31 %9.81 %
201457.37 %13.96 %9.7 %
201357.43 %14.24 %9.67 %
201257.43 %13.91 %10.02 %
201158.35 %14.71 %8.94 %
201057.28 %14.24 %7.14 %
200955.73 %13.2 %7.16 %
200854.76 %12.59 %7.04 %
200733.6 %6.24 %3.72 %
200631.56 %5.62 %3.23 %
200531.13 %5.72 %3.01 %
200432.07 %6.03 %3.1 %

Kobayashi Pharmaceutical Co Aktienanalyse

What does Kobayashi Pharmaceutical Co do?

Kobayashi Pharmaceutical Co Ltd is a Japanese company that specializes in the production of health products. Kobayashi Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Kobayashi Pharmaceutical Co's Sales Figures

The sales figures of Kobayashi Pharmaceutical Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Kobayashi Pharmaceutical Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Kobayashi Pharmaceutical Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Kobayashi Pharmaceutical Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Kobayashi Pharmaceutical Co stock

How much revenue did Kobayashi Pharmaceutical Co generate this year?

Kobayashi Pharmaceutical Co has achieved a revenue of 174.69 B JPY this year.

How much was the turnover of the company Kobayashi Pharmaceutical Co compared to the previous year?

The revenue of Kobayashi Pharmaceutical Co has increased by 0.71% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Kobayashi Pharmaceutical Co?

The revenue of Kobayashi Pharmaceutical Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Kobayashi Pharmaceutical Co measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Kobayashi Pharmaceutical Co so important for investors?

The revenue of Kobayashi Pharmaceutical Co is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Kobayashi Pharmaceutical Co pay?

Over the past 12 months, Kobayashi Pharmaceutical Co paid a dividend of 101 JPY . This corresponds to a dividend yield of about 1.84 %. For the coming 12 months, Kobayashi Pharmaceutical Co is expected to pay a dividend of 107.77 JPY.

What is the dividend yield of Kobayashi Pharmaceutical Co?

The current dividend yield of Kobayashi Pharmaceutical Co is 1.84 %.

When does Kobayashi Pharmaceutical Co pay dividends?

Kobayashi Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of July, January, July, January.

How secure is the dividend of Kobayashi Pharmaceutical Co?

Kobayashi Pharmaceutical Co paid dividends every year for the past 23 years.

What is the dividend of Kobayashi Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 107.77 JPY are expected. This corresponds to a dividend yield of 1.96 %.

In which sector is Kobayashi Pharmaceutical Co located?

Kobayashi Pharmaceutical Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Kobayashi Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kobayashi Pharmaceutical Co from 3/1/2025 amounting to 59 JPY, you needed to have the stock in your portfolio before the ex-date on 12/27/2024.

When did Kobayashi Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 3/1/2025.

What was the dividend of Kobayashi Pharmaceutical Co in the year 2023?

In the year 2023, Kobayashi Pharmaceutical Co distributed 90 JPY as dividends.

In which currency does Kobayashi Pharmaceutical Co pay out the dividend?

The dividends of Kobayashi Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kobayashi Pharmaceutical Co

Our stock analysis for Kobayashi Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kobayashi Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.